Physician

Shelley Day Ghafoori, MD

According to 2025 Medicare claims, Shelley Ghafoori, MD (NPI: 1588788830) practices ophthalmology in the Austin-Round Rock-San Marcos, TX market, with the plurality of this provider's patient population coming from Travis, TX. This provider's primary affiliated billing organization is AUSTIN RETINA ASSOCIATES PLLC (NPI: 1114999828; TIN: 74-2034080) and primary practice location at 78705-1169.

Ghafoori's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,005 traditional Medicare patients, billed 20,523 HCPCS/CPT codes, and received $2,881,716 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 294 prescription claims across 103 beneficiaries totaling $13,121 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 8 records totaling $10,902. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $809,503 to $2,881,716. In contrast, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $46,154 to $13,121. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.4M$2.9M2015 Medicare payment: $809,503 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,049,926 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,264,264 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,532,987 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,052,809 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,175,693 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,221,025 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,311,412 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,850,615 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,881,716 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156705,862$809,503
20166956,415$1,049,926
20177626,760$1,264,264
20188587,465$1,532,987
20199579,029$2,052,809
20208898,899$2,175,693
20219589,368$2,221,025
202296811,404$2,311,412
20231,00225,135$2,850,615
20241,00520,523$2,881,716

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$23K$46K2015 Drug cost: $46,154 (USD; Tot_Drug_Cst)2016 Drug cost: $14,399 (USD; Tot_Drug_Cst)2017 Drug cost: $11,185 (USD; Tot_Drug_Cst)2018 Drug cost: $14,411 (USD; Tot_Drug_Cst)2019 Drug cost: $13,668 (USD; Tot_Drug_Cst)2020 Drug cost: $20,451 (USD; Tot_Drug_Cst)2021 Drug cost: $16,397 (USD; Tot_Drug_Cst)2022 Drug cost: $13,715 (USD; Tot_Drug_Cst)2023 Drug cost: $22,150 (USD; Tot_Drug_Cst)2024 Drug cost: $13,121 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201571206$46,154
201672175$14,399
201770154$11,185
201899245$14,411
201977185$13,668
202074211$20,451
202181180$16,397
202268189$13,715
202381222$22,150
2024103294$13,121

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye3291,424$98
92014Established patient complete exam of visual system461584$90
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more320587$70
92134Imaging of retina7552,019$31
92250Photography of the retina441650$28

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1304,089$4,534
Bromfenac SodiumBromfenac Sodium30536$2,569
Ketorolac TromethamineKetorolac Tromethamine29935$1,119
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol13623$1,072
LatanoprostLatanoprost14662$125

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.7$816ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.1$10,086Novartis Pharmaceuticals Corporation
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Shelley Day Ghafoori, MD?

Tedicare shows public-source Medicare data for Shelley Day Ghafoori, MD (NPI 1588788830), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Shelley Day Ghafoori, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Shelley Day Ghafoori, MD?

Shelley Day Ghafoori, MD is linked to AUSTIN RETINA ASSOCIATES PLLC (billing NPI 1114999828) in the available physician profile data.

Does Shelley Day Ghafoori, MD have Open Payments data?

Shelley Day Ghafoori, MD has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.